- Home
- GORV vs FEMY Comparison
GORV vs FEMY Comparison
Compare GORV & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- FEMY
- Stock Information
- Founded
- GORV 1976
- FEMY 2004
- Country
- GORV United States
- FEMY United States
- Employees
- GORV N/A
- FEMY N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- FEMY Medical/Dental Instruments
- Sector
- GORV Consumer Discretionary
- FEMY Health Care
- Exchange
- GORV Nasdaq
- FEMY Nasdaq
- Market Cap
- GORV 10.6M
- FEMY 12.5M
- IPO Year
- GORV 2015
- FEMY 2021
- Fundamental
- Price
- GORV $3.06
- FEMY $0.37
- Analyst Decision
- GORV
- FEMY Strong Buy
- Analyst Count
- GORV 0
- FEMY 3
- Target Price
- GORV N/A
- FEMY $7.33
- AVG Volume (30 Days)
- GORV 950.5K
- FEMY 2.9M
- Earning Date
- GORV 08-14-2025
- FEMY 11-11-2025
- Dividend Yield
- GORV N/A
- FEMY N/A
- EPS Growth
- GORV N/A
- FEMY N/A
- EPS
- GORV N/A
- FEMY N/A
- Revenue
- GORV $662,952,000.00
- FEMY $1,887,016.00
- Revenue This Year
- GORV $15.65
- FEMY $103.55
- Revenue Next Year
- GORV $20.54
- FEMY $148.13
- P/E Ratio
- GORV N/A
- FEMY N/A
- Revenue Growth
- GORV N/A
- FEMY 98.61
- 52 Week Low
- GORV $2.22
- FEMY $0.31
- 52 Week High
- GORV $58.80
- FEMY $1.80
- Technical
- Relative Strength Index (RSI)
- GORV 43.41
- FEMY 44.59
- Support Level
- GORV $2.30
- FEMY N/A
- Resistance Level
- GORV $2.89
- FEMY $0.40
- Average True Range (ATR)
- GORV 0.60
- FEMY 0.04
- MACD
- GORV 0.08
- FEMY -0.00
- Stochastic Oscillator
- GORV 18.67
- FEMY 64.91
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.